DURECT
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch DURECT and buy or sell other stocks, ETFs, and their options commission-free!About DRRX
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator.
CEOJames E. Brown, DVM
CEOJames E. Brown, DVM
Employees31
Employees31
HeadquartersCupertino, California
HeadquartersCupertino, California
Founded1998
Founded1998
Employees31
Employees31
DRRX Key Statistics
Market cap23.17M
Market cap23.17M
Price-Earnings ratio-4.09
Price-Earnings ratio-4.09
Dividend yield—
Dividend yield—
Average volume521.17K
Average volume521.17K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$2.64
52 Week high$2.64
52 Week low$0.4801
52 Week low$0.4801
Stock Snapshot
DURECT(DRRX) stock is priced at $0.75, giving the company a market capitalization of 23.17M. It carries a P/E multiple of -4.09.
During the trading day, DURECT(DRRX) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading activity shows a volume of 0, compared to an average daily volume of 521.17K.
Over the past 52 weeks, DURECT(DRRX) stock has traded between a high of $2.64 and a low of $0.48.
Over the past 52 weeks, DURECT(DRRX) stock has traded between a high of $2.64 and a low of $0.48.
People also own
Based on the portfolios of people who own DRRX. This list is generated using Robinhood data, and it’s not a recommendation.